<?xml version="1.0" ?>
<!DOCTYPE pmc-articleset PUBLIC "-//NLM//DTD ARTICLE SET 2.0//EN" "https://dtd.nlm.nih.gov/ncbi/pmc/articleset/nlm-articleset-2.0.dtd">
<pmc-articleset><article xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" article-type="case-report">
  <?properties open_access?>
  <front>
    <journal-meta>
      <journal-id journal-id-type="nlm-ta">Indian J Ophthalmol</journal-id>
      <journal-id journal-id-type="iso-abbrev">Indian J Ophthalmol</journal-id>
      <journal-id journal-id-type="publisher-id">IJO</journal-id>
      <journal-title-group>
        <journal-title>Indian Journal of Ophthalmology</journal-title>
      </journal-title-group>
      <issn pub-type="ppub">0301-4738</issn>
      <issn pub-type="epub">1998-3689</issn>
      <publisher>
        <publisher-name>Medknow Publications &amp; Media Pvt Ltd</publisher-name>
        <publisher-loc>India</publisher-loc>
      </publisher>
    </journal-meta>
    <article-meta>
      <article-id pub-id-type="pmid">23571261</article-id>
      <article-id pub-id-type="pmc">4061688</article-id>
      <article-id pub-id-type="publisher-id">IJO-62-367</article-id>
      <article-id pub-id-type="doi">10.4103/0301-4738.109523</article-id>
      <article-categories>
        <subj-group subj-group-type="heading">
          <subject>Brief Communications</subject>
        </subj-group>
      </article-categories>
      <title-group>
        <article-title>Collagen cross-linking in the treatment of pellucid marginal degeneration</article-title>
      </title-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name>
            <surname>Hassan</surname>
            <given-names>Ziad</given-names>
          </name>
          <xref ref-type="aff" rid="aff1"/>
          <xref ref-type="corresp" rid="cor1"/>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Nemeth</surname>
            <given-names>Gabor</given-names>
          </name>
          <xref ref-type="aff" rid="aff2">1</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Modis</surname>
            <given-names>Laszlo</given-names>
          </name>
          <xref ref-type="aff" rid="aff2">1</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Szalai</surname>
            <given-names>Eszter</given-names>
          </name>
          <xref ref-type="aff" rid="aff2">1</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Berta</surname>
            <given-names>Andras</given-names>
          </name>
          <xref ref-type="aff" rid="aff2">1</xref>
        </contrib>
      </contrib-group>
      <aff id="aff1">Orbident Refractive Surgery and Medical Center, University of Debrecen, Debrecen, Hungary</aff>
      <aff id="aff2"><label>1</label>Department of Ophthalmology, Medical and Health Science Center, University of Debrecen, Debrecen, Hungary</aff>
      <author-notes>
        <corresp id="cor1"><bold>Correspondence to:</bold> Dr. Ziad Hassan, Orbident Refractive Surgery and Medical Center, Debrecen, Hungary, Nagyerdei blvd. 98, H-4012 Debrecen, Hungary. E-mail: <email xlink:href="zhassan@dote.hu">zhassan@dote.hu</email></corresp>
      </author-notes>
      <pub-date pub-type="ppub">
        <month>3</month>
        <year>2014</year>
      </pub-date>
      <volume>62</volume>
      <issue>3</issue>
      <fpage>367</fpage>
      <lpage>370</lpage>
      <history>
        <date date-type="received">
          <day>04</day>
          <month>8</month>
          <year>2011</year>
        </date>
        <date date-type="accepted">
          <day>14</day>
          <month>3</month>
          <year>2012</year>
        </date>
      </history>
      <permissions>
        <copyright-statement>Copyright: &#xA9; Indian Journal of Ophthalmology</copyright-statement>
        <copyright-year>2014</copyright-year>
        <license license-type="open-access" xlink:href="http://creativecommons.org/licenses/by-nc-sa/3.0">
          <license-p>This is an open-access article distributed under the terms of the Creative Commons Attribution-Noncommercial-Share Alike 3.0 Unported, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.</license-p>
        </license>
      </permissions>
      <abstract>
        <p>Pellucid marginal degeneration (PMD) is an uncommon cause of inferior peripheral corneal thinning disorder, characterized by irregular astigmatism. We analyzed a case of bilateral PMD patient and treated one eye with corneal collagen cross-linking (CXL) therapy. Corneal topography was characteristic for PMD. Visual acuity, slitlamp examinations, tonometry, and corneal thickness were observed. Simulated keratometric and topographic index values were detected with corneal topography. Uncorrected, LogMAR visual acuity has improved from +0.8 to +0.55 during the 6 months and +0.3 during the 8 months follow-up after CXL. Pachymetry values and intraocular pressure showed no changes. Keratometric values and topografic indexes disclosed no progression of the disease. CXL may postpone or eliminate the need of corneal transplantation in cases with PMD.</p>
      </abstract>
      <kwd-group>
        <kwd>Collagen cross-linking</kwd>
        <kwd>pellucid marginal degeneration</kwd>
        <kwd>Pentacam HR</kwd>
      </kwd-group>
    </article-meta>
  </front>
  <body>
    <p>Pellucid marginal degeneration (PMD) of the cornea is a progressive, rare, and uncommon noninflammatory corneal disorder characterized by the thinning in the peripheral portion of the inferior cornea with marked steepening just superior to the thinned zone.[<xref rid="ref1" ref-type="bibr">1</xref><xref rid="ref2" ref-type="bibr">2</xref>] It occurs in both men and women and can be differentiated from other peripheral corneal thinning disorders such as keratoconus and keratoglobus by its characteristics that this thinning occurs 1&#x2013;3 mm from the limbus in the 4&#x2013;8 o&#x2019;clock position.[<xref rid="ref3" ref-type="bibr">3</xref>] It is differentiated from peripheral corneal disorders associated with inflammation such as Terrien's marginal degeneration and Mooren's ulcer by the absence of vascularisation. Although histopathologically it is considered a variant of keratoconus, it differs in that the marked corneal steepening occurs more inferiorly.[<xref rid="ref1" ref-type="bibr">1</xref>]</p>
    <p>Corneal cross-linking was introduced by Wollensak <italic>et al</italic>. in 2003 for the treatment of progressive keratoconus and related disorders increasing the biomechanical strength of the cornea by about 300%.[<xref rid="ref4" ref-type="bibr">4</xref>]</p>
    <p>Here we present one case showing the features of PMD both clinically and topographically treated by collagen cross-linking (CXL). It was clinically typical bilateral PMD with a characteristic pattern of irregular astigmatism on corneal topography, with chief complaints of progressive dimness of vision caused by irregular astigmatism. The CXL treatment can stop PMD progression and produce better quality of vision.</p>
    <sec id="sec1-2">
      <title>Case Report</title>
      <p>We analyzed a case of advanced bilateral PMD patient and treated one eye with corneal CXL. A 55-year-old male is presented, complaining of progressive dimness of vision in both eyes with decreased vision started 1 year before examinations at our clinic, but the visual loss was larger in the right eye. There was no history of excessive eye rubbing, trauma, contact lens wear, or episodic redness of the eye. There was no familiar history. Earlier, he was diagnosed with glaucoma simplex treated with timolol 0.5%. His right eye was pseudophakic, and his left eye had posterior subcapsular cataract. He had high blood pressure and type II diabetes mellitus was treated for around 9 years. The patient tried rigid gas-permeable contact lenses but could never get an acceptable fit. Visual acuity, slitlamp examination, corneal thickness map measurement (Pentacam HR, Oculus), and tonometry were carried out, and simulated keratometric (SK1, SK2) and topographic index values were detected with corneal topograph (Tomey TMS4).</p>
      <p>Ophthalmic examination revealed his best-uncorrected visual acuity, a value of +0.8 in the right eye and +0.1 in the left eye observed with a logarithmic scale (LogMAR). Slitlamp examination of the cornea showed inferior peripheral corneal-thinning without iron lines, vascularization, or lipid deposition [<xref ref-type="fig" rid="F1">Fig. 1</xref>]. The lesion was nonulcerative and inflammatory, and implied the protrusion of the cornea. Between the thinned area and the limbus, the corneal thickness was normal. However, the left eye showed a clear band of peripheral thinning about 1&#x2013;2 mm wide, with anterior protrusion of the cornea just above the thinned area. A 2.0-mm zone of normal-thickness cornea was seen between the thinned area and the limbus. Scheimpflug image (Oculus Pentacam HR) of the anterior segment of the right eye shows irregular shaped central corneal region [Fig. <xref ref-type="fig" rid="F2">2a</xref> and <xref ref-type="fig" rid="F2">b</xref>].</p>
      <fig id="F1" position="float">
        <label>Figure 1</label>
        <caption>
          <p>Slit-lamp photograph of the right eye shows inferior steepening with a clear zone between limbus and the steep band</p>
        </caption>
        <graphic xlink:href="IJO-62-367-g001"/>
      </fig>
      <fig id="F2" position="float">
        <label>Figure 2</label>
        <caption>
          <p>(a and b) Scheimpflug image (Oculus Pentacam HR) of the anterior segment shows irregular shaped central corneal region</p>
        </caption>
        <graphic xlink:href="IJO-62-367-g002"/>
      </fig>
      <p>Both anterior chambers were 4.11 mm deep. Corneal thickness measured by ultrasonic pachymeter of the right eye were 502 &#x3BC;m centrally and 520 &#x3BC;m peripherally; in the left eye, the readings were 540 &#x3BC;m centrally, and 520 &#x3BC;m at the periphery. The intraocular pressure measured by noncontact tonometry was in normal range in both eyes.</p>
      <p>Corneal topography was characteristic for PMD. The vertical axis images showed significant central irregular against-the-rule astigmatism, marked peripheral thinning within 2.0 mm of the limbus, and more normal corneal thickness inferior to the band of thinning. Topograph sagittal curvature map on the right eye showed vertical flatting and irregular inferior corneal astigmatism. The horizontal axis had more normal corneal contour and thickness. Keratometric readings were 53.98D/36.04D in the right eye. In both eyes, there was a bow-tie-shaped corneal astigmatism with a value of 17.96D in the right eye [<xref ref-type="fig" rid="F3">Fig. 3</xref>]. This clinical picture was consistent with a diagnosis of PMD of both eyes.</p>
      <fig id="F3" position="float">
        <label>Figure 3</label>
        <caption>
          <p>Preoperative corneal topographic picture of the right eye shows the characteristic bow-tie appearance of corneal steepening (red zones) and midperipheral inferior corneal flattening</p>
        </caption>
        <graphic xlink:href="IJO-62-367-g003"/>
      </fig>
      <p>CXL was performed on the right eye using InPro CCL-Lix device (Norderstadt, Germany). During treatment, 8 mm of the central corneal epithelium was removed and 0.1% riboflavin solution (with 20% dextrane) was instilled on the surface of the cornea with eccentric method of Spadea[<xref rid="ref5" ref-type="bibr">5</xref>] and was repeated every 2 minutes thereafter. In the meantime, UV-A irradiation was performed with an emission at 370 nm, with radiant energy of 3 mW/cm<sup>2</sup>, focusing distance of 60 mm, and lasted for 30 minutes. The postoperative treatment was antiobiotic eye drops for 5 days (tobramycin) and steroid eyedrops (fluorometholone) and artificial tear drops for at least 1 month. We did not use contact lens postoperatively. There was no corneal edema or endothelial damage postoperatively.</p>
      <p>The follow-up period was 8 months. Visual acuity, simulated keratometric indexes, and corneal thickness values were detected during the postoperative period. Uncorrected visual acuity has increased from +0.8 to +0.55; best-corrected visual acuity was +0.25 with a correction of spherical equivalent of -4.0 D 8 months after CXL treatment. After CXL treatment, SK1 decreased to 50.48 D and SK2 to 33.97 D [<xref ref-type="fig" rid="F4">Fig. 4</xref>]. Pre- and postoperative corneal back surface Scheimpflug pictures (Pentacam HR) do not show difference [<xref ref-type="fig" rid="F5">Fig. 5</xref>].</p>
      <fig id="F4" position="float">
        <label>Figure 4</label>
        <caption>
          <p>Corneal topograph shows flattening of the inferior cornea 8 months after CXL treatment</p>
        </caption>
        <graphic xlink:href="IJO-62-367-g004"/>
      </fig>
      <fig id="F5" position="float">
        <label>Figure 5</label>
        <caption>
          <p>Pre-and postoperative corneal back surface Scheimpflug pictures (Pentacam HR) do not show difference</p>
        </caption>
        <graphic xlink:href="IJO-62-367-g005"/>
      </fig>
      <p>Pachymetry map showed minimal increase in peripheral corneal thickness (from 520 &#x3BC;m preoperatively to 528 &#x3BC;m postoperatively) 8 months after treatment. No change in intraocular pressure was measured, during the follow-up period. IOP varied between 14 and 19 mmHg. Our data are summarized in Tables <xref ref-type="table" rid="T1">1</xref> and <xref ref-type="table" rid="T2">2</xref>.</p>
      <table-wrap id="T1" position="float">
        <label>Table 1</label>
        <caption>
          <p>Patient data before and after collage cross-linking treatment</p>
        </caption>
        <graphic xlink:href="IJO-62-367-g006"/>
      </table-wrap>
      <table-wrap id="T2" position="float">
        <label>Table 2</label>
        <caption>
          <p>Patient data before and after surgery</p>
        </caption>
        <graphic xlink:href="IJO-62-367-g007"/>
      </table-wrap>
    </sec>
    <sec sec-type="discussion" id="sec1-3">
      <title>Discussion</title>
      <p>PMD has been postulated to the abnormality of the connective tissue, but the exact pathogenesis is still unknown. On corneal topography, marked steepening of the inferior corneal periphery can be seen, which also extends into mid-peripheral inferior corneal meridians. The mid-peripheral cornea is gradually decreased in keratometric power above the inferior oblique meridians.[<xref rid="ref3" ref-type="bibr">3</xref><xref rid="ref6" ref-type="bibr">6</xref>] Our patient had all these features in both eyes, and there was no stromal thickness less than 400 &#x3BC;m, but the left eye showed less deviation than the right eye. The usual treatments for PMD are intrastromal ring insertion, lamellar keratoplasty, crescentic lamellar keratoplasty, penetrating keratoplasty, cyanoacrylate adhesive, and a bandage contact lens. Conservative treatment is also possible.[<xref rid="ref7" ref-type="bibr">7</xref>]</p>
      <p>Corneal transplantation for keratectasia is a difficult procedure with a long and uncertain visual recovery. Ertan <italic>et al</italic>.[<xref rid="ref8" ref-type="bibr">8</xref>] inserted intacs ring using a femtosecond laser to correct pellucid marginal corneal degeneration with safe and efficient results. In the report of Stojanovic <italic>et al</italic>., 12 eyes were treated with topography-guided custom ablation and CXL, which after uncorrected visual acuity increased and astigmatism and keratometric asymmetry decreased.[<xref rid="ref9" ref-type="bibr">9</xref>] Spadea described eccentric irradiation CXL technique followed by us in case of PMD.[<xref rid="ref5" ref-type="bibr">5</xref>] Kymionis <italic>et al</italic>.[<xref rid="ref10" ref-type="bibr">10</xref>] treated a woman with simultaneous photorefractive keratectomy and corneal CXL with riboflavin-ultraviolet-A irradiation for the treatment of progressive pellucid marginal corneal degeneration in both eyes with good results. Histologically and clinically, CXL is a well-circumscribed and well-published therapic possibility of corneal ectasias.[<xref rid="ref11" ref-type="bibr">11</xref><xref rid="ref12" ref-type="bibr">12</xref>] There are some possible complications after CXL: early pseudo-haze, bacterial infection,[<xref rid="ref13" ref-type="bibr">13</xref>] scarring, melting, or perforation. The safety parameter of a minimal stromal thickness of 400 &#x3BC;m to spare the endothelium.[<xref rid="ref14" ref-type="bibr">14</xref>]</p>
      <p>In this case, progression had been stopped by CXL treatment, and the best-corrected visual acuity increased during the observation period. No intraoperative or early postoperative complications occurred. The CXL irradiation was safe and efficient in the treatment of certain stages of PMDs with the help of which progression can be reversed or at least stopped, and visual acuity can be improved. This method may postpone or eliminate the need of corneal transplantation in cases with PMD.</p>
    </sec>
  </body>
  <back>
    <fn-group>
      <fn fn-type="supported-by">
        <p><bold>Source of Support:</bold> Nil.</p>
      </fn>
      <fn fn-type="conflict">
        <p><bold>Conflict of Interest:</bold> None declared.</p>
      </fn>
    </fn-group>
    <ref-list>
      <ref id="ref1">
        <label>1</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Krachmer</surname>
              <given-names>JH</given-names>
            </name>
          </person-group>
          <article-title>Pellucid marginal degeneration</article-title>
          <source>Arch Ophthalmol</source>
          <year>1978</year>
          <volume>96</volume>
          <fpage>1217</fpage>
          <lpage>21</lpage>
          <pub-id pub-id-type="pmid">352310</pub-id>
        </element-citation>
      </ref>
      <ref id="ref2">
        <label>2</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Walker</surname>
              <given-names>RN</given-names>
            </name>
            <name>
              <surname>Khachikian</surname>
              <given-names>SS</given-names>
            </name>
            <name>
              <surname>Belin</surname>
              <given-names>MW</given-names>
            </name>
          </person-group>
          <article-title>Scheimpflug photographic diagnosis of pellucid marginal degeneration</article-title>
          <source>Cornea</source>
          <year>2008</year>
          <volume>27</volume>
          <fpage>963</fpage>
          <lpage>6</lpage>
          <pub-id pub-id-type="pmid">18724166</pub-id>
        </element-citation>
      </ref>
      <ref id="ref3">
        <label>3</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Krachmer</surname>
              <given-names>JH</given-names>
            </name>
            <name>
              <surname>Feder</surname>
              <given-names>RS</given-names>
            </name>
            <name>
              <surname>Belin</surname>
              <given-names>MW</given-names>
            </name>
          </person-group>
          <article-title>Keratoconus and related noninflammatory corneal thinning disorders</article-title>
          <source>Surv Ophthalmol</source>
          <year>1984</year>
          <volume>28</volume>
          <fpage>293</fpage>
          <lpage>322</lpage>
          <pub-id pub-id-type="pmid">6230745</pub-id>
        </element-citation>
      </ref>
      <ref id="ref4">
        <label>4</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Wollensak</surname>
              <given-names>G</given-names>
            </name>
            <name>
              <surname>Spoerl</surname>
              <given-names>E</given-names>
            </name>
            <name>
              <surname>Seiler</surname>
              <given-names>T</given-names>
            </name>
          </person-group>
          <article-title>Riboflavin/ultraviolet-A-induced collagen cross linking for the treatment of keratoconus</article-title>
          <source>J Cataract Refract Surg</source>
          <year>2003</year>
          <volume>135</volume>
          <fpage>620</fpage>
          <lpage>7</lpage>
        </element-citation>
      </ref>
      <ref id="ref5">
        <label>5</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Spadea</surname>
              <given-names>L</given-names>
            </name>
          </person-group>
          <article-title>Corneal collagen cross-linking with riboflavin and UVA irradiation in pellucid marginal degeneration</article-title>
          <source>J Refract Surg</source>
          <year>2010</year>
          <volume>26</volume>
          <fpage>375</fpage>
          <lpage>7</lpage>
          <pub-id pub-id-type="pmid">20128533</pub-id>
        </element-citation>
      </ref>
      <ref id="ref6">
        <label>6</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Klyce</surname>
              <given-names>SD</given-names>
            </name>
          </person-group>
          <article-title>Computer-assisted corneal topography: high resolution graphic presentation and analysis of keratoscopy</article-title>
          <source>Invest Ophthalmol Vis Sci</source>
          <year>1984</year>
          <volume>25</volume>
          <fpage>1426</fpage>
          <lpage>35</lpage>
          <pub-id pub-id-type="pmid">6511226</pub-id>
        </element-citation>
      </ref>
      <ref id="ref7">
        <label>7</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Forooghian</surname>
              <given-names>F</given-names>
            </name>
            <name>
              <surname>Assaad</surname>
              <given-names>D</given-names>
            </name>
            <name>
              <surname>Dixon</surname>
              <given-names>WS</given-names>
            </name>
          </person-group>
          <article-title>Successful conservative treatment of hydrops with perforation in pellucid marginal degeneration</article-title>
          <source>Can J Ophthalmol</source>
          <year>2006</year>
          <volume>41</volume>
          <fpage>74</fpage>
          <lpage>7</lpage>
          <pub-id pub-id-type="pmid">16462877</pub-id>
        </element-citation>
      </ref>
      <ref id="ref8">
        <label>8</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Ertan</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Bahadit</surname>
              <given-names>M</given-names>
            </name>
          </person-group>
          <article-title>Intrastromal ring segment insertion using a femtosecond laser to correct pellucid marginal corneal degeneration</article-title>
          <source>J Cataract Refract Surg</source>
          <year>2006</year>
          <volume>32</volume>
          <fpage>1710</fpage>
          <lpage>6</lpage>
          <pub-id pub-id-type="pmid">17010872</pub-id>
        </element-citation>
      </ref>
      <ref id="ref9">
        <label>9</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Stojanovic</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Zhang</surname>
              <given-names>J</given-names>
            </name>
            <name>
              <surname>Chen</surname>
              <given-names>X</given-names>
            </name>
            <name>
              <surname>Nitter</surname>
              <given-names>TA</given-names>
            </name>
            <name>
              <surname>Chen</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Wang</surname>
              <given-names>Q</given-names>
            </name>
          </person-group>
          <article-title>Topography-guided transepithelial surface ablation followed by corneal collagen cross-linking performed in a single combined procedure for the treatment of keratoconus and pellucid marginal degeneration</article-title>
          <source>J Refract Surg</source>
          <year>2010</year>
          <volume>26</volume>
          <fpage>145</fpage>
          <lpage>52</lpage>
          <pub-id pub-id-type="pmid">20163079</pub-id>
        </element-citation>
      </ref>
      <ref id="ref10">
        <label>10</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Kymionis</surname>
              <given-names>GD</given-names>
            </name>
            <name>
              <surname>Karavitaki</surname>
              <given-names>AE</given-names>
            </name>
            <name>
              <surname>Kounis</surname>
              <given-names>GA</given-names>
            </name>
            <name>
              <surname>Portaliou</surname>
              <given-names>DM</given-names>
            </name>
            <name>
              <surname>Yoo</surname>
              <given-names>SH</given-names>
            </name>
            <name>
              <surname>Pallikaris</surname>
              <given-names>IG</given-names>
            </name>
          </person-group>
          <article-title>Management of pellucid marginal corneal degeneration with simultaneous customized photorefractive keratectomy and collagen crosslinking</article-title>
          <source>J Cataract Refract Surg</source>
          <year>2009</year>
          <volume>35</volume>
          <fpage>1298</fpage>
          <lpage>301</lpage>
          <pub-id pub-id-type="pmid">19545822</pub-id>
        </element-citation>
      </ref>
      <ref id="ref11">
        <label>11</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Wollensak</surname>
              <given-names>G</given-names>
            </name>
          </person-group>
          <article-title>Crosslinking treatment of progressive keratoconus: New hope</article-title>
          <source>Curr Opin Ophthalmol</source>
          <year>2006</year>
          <volume>17</volume>
          <fpage>356</fpage>
          <lpage>60</lpage>
          <pub-id pub-id-type="pmid">16900027</pub-id>
        </element-citation>
      </ref>
      <ref id="ref12">
        <label>12</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Wollensak</surname>
              <given-names>G</given-names>
            </name>
          </person-group>
          <article-title>Corneal collagen cross-linking: New horizons</article-title>
          <source>Expert Rev Ophthalmol</source>
          <year>2010</year>
          <volume>5</volume>
          <fpage>201</fpage>
          <lpage>15</lpage>
        </element-citation>
      </ref>
      <ref id="ref13">
        <label>13</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Sharma</surname>
              <given-names>N</given-names>
            </name>
            <name>
              <surname>Maharana</surname>
              <given-names>P</given-names>
            </name>
            <name>
              <surname>Singh</surname>
              <given-names>G</given-names>
            </name>
            <name>
              <surname>Titiyal</surname>
              <given-names>JS</given-names>
            </name>
          </person-group>
          <article-title>Pseudomonas keratitis after collagen crosslinking for keratoconus: Case report and review of literature</article-title>
          <source>J Cataract Refract Surg</source>
          <year>2010</year>
          <volume>36</volume>
          <fpage>517</fpage>
          <lpage>20</lpage>
          <pub-id pub-id-type="pmid">20202556</pub-id>
        </element-citation>
      </ref>
      <ref id="ref14">
        <label>14</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Wollensak</surname>
              <given-names>G</given-names>
            </name>
            <name>
              <surname>Spoerl</surname>
              <given-names>E</given-names>
            </name>
            <name>
              <surname>Wilsch</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Seiler</surname>
              <given-names>T</given-names>
            </name>
          </person-group>
          <article-title>Endothelial cell damage after riboflavin-ultraviolet-A treatment in the rabbit</article-title>
          <source>J Cataract Refract Surg</source>
          <year>2003</year>
          <volume>29</volume>
          <fpage>1786</fpage>
          <lpage>90</lpage>
          <pub-id pub-id-type="pmid">14522302</pub-id>
        </element-citation>
      </ref>
    </ref-list>
  </back>
</article>
</pmc-articleset>
